Stocksigma LogoStocksigma Logo

Jenburkt Pharmaceuticals Schedules Board Meeting to Consider Q2 FY27 Results

Jenburkt Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 3rd Nov'26 to consider and approve the standalone unaudited financial

Jenburkt Pharmaceuticals Schedules Board Meeting to Consider Q2 FY27 Results

Jenburkt Pharmaceuticals Ltd 路 Intimation 路 03 Nov 2026, 5:30 am

Jenburkt Pharmaceuticals Schedules Board Meeting to Consider Q2 FY27 Results Jenburkt Pharmaceuticals Limited has scheduled a meeting of its Board of Directors on 3rd Nov'26 to consider and approve the standalone unaudited financial results for the quarter and half year ended 30th Sep'26.

Original exchange filing (PDF)

More announcements from Jenburkt Pharmaceuticals Ltd

All Jenburkt Pharmaceuticals Ltd announcements